Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1

In both studies, females in primary prevention have a better cardiovascular risk profile than males. We observed a high rate of therapeutic inertia, which might be higher in females for statin treatment and nephroprotection with ACEi-ARB, especially in Germany. Diabetologists should be aware of sex-specific differences in the management of cardiorenal risk factors to develop more personalized prevention strategies.

Authors

Institutions

Publication Details

Journal
Cardiovascular Diabetology
Published
2024-09-16
DOI
https://doi.org/10.1186/s12933-024-02419-4
Citations
8
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
2.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1

Reinhard W. Holl, Petra Augstein, Jean‐Pierre Riveline, Emmanuel Cosson et al.
8 citations
Cardiovascular Diabetology
Diabetes Management and Research
2.86
article

Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1

Reinhard W. Holl, Petra Augstein, Jean‐Pierre Riveline, Emmanuel Cosson, Guy Fagherazzi, Marie Auzanneau, Gloria Aguayo, Laura Sablone, Peter Jehle, Wölfram Karges
article en
8 citations

Abstract

In both studies, females in primary prevention have a better cardiovascular risk profile than males. We observed a high rate of therapeutic inertia, which might be higher in females for statin treatment and nephroprotection with ACEi-ARB, especially in Germany. Diabetologists should be aware of sex-specific differences in the management of cardiorenal risk factors to develop more personalized prevention strategies.

Cardiovascular DiabetologyVol. 23(1)
Conservatoire National des Arts et Métiers (FR), Hôpital Necker-Enfants Malades (FR), Centre National de la Recherche Scientifique (FR), Inserm (FR), Wittenberg University (US), Universität Ulm (DE), Université Paris Cité (FR), Luther University (KR), Sorbonne Université (FR), Institut Necker Enfants Malades (FR), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR), Université Sorbonne Paris Nord (FR), Sorbonne Paris Cité (FR), Assistance Publique – Hôpitaux de Paris (FR), Luxembourg Institute of Health (LU), Hôpital Fernand-Widal (FR), Hôpital Lariboisière (FR), Universitätsklinikum Aachen (DE), Hôpital Avicenne (FR), Helmholtz-Institute Ulm (DE), Hôtel-Dieu de Paris (FR), Institute for Diabetes Gerhardt Katsch (DE), Deutsches Diabetes-Zentrum e.V. (DE), Société Francophone du Diabète (FR), German Center for Diabetes Research (DE), Centre de Recherche Épidémiologie et Statistique (FR), Heinrich Heine University Düsseldorf (DE), Martin Luther University Halle-Wittenberg (DE), RWTH Aachen University (DE)
Eli Lilly and Company, Sanofi, Insulet Corporation, Dexcom, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Fondation Francophone pour la Recherche sur le Diabète, Bundesministerium für Bildung und Forschung, Novo Nordisk, Société Francophone du Diabète, Robert Koch Institut
Openalex Percentile: Top 8%
Diabetes Management and Research
2.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.